Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat. - Röttgen H; Theurer L; Peccerella T; Sandu K; Weiss J; Burhenne J; Neoptolemos JP; Köberle B; Theile D (Oncology reports, 2026)